편집
13,127
번
잔글 (→관련 연구) |
잔글 (→관련 연구) |
||
50번째 줄: | 50번째 줄: | ||
* [[SUSTAIN]] | * [[SUSTAIN]] | ||
* [[PrONTO]] (Prospective OCT Imaging of Patients with Neovascular AMD Treated with intraOcular Ranibizumab)<ref>Fung AE et al. An OCT-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for wAMD. ''AJO''. 2007 Apr;143(4):566-83. [https://pubmed.ncbi.nlm.nih.gov/17386270/ 연결]</ref> | * [[PrONTO]] (Prospective OCT Imaging of Patients with Neovascular AMD Treated with intraOcular Ranibizumab)<ref>Fung AE et al. An OCT-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for wAMD. ''AJO''. 2007 Apr;143(4):566-83. [https://pubmed.ncbi.nlm.nih.gov/17386270/ 연결]</ref> | ||
* [[HORIZON]] | * [[HORIZON]]<ref>Singer MA et al. HORIZON: an open-label extension trial of ranibizumab for CNV secondary to AMD. ''Ophthalmology''. 2012 Jun;119(6):1175-83. [https://pubmed.ncbi.nlm.nih.gov/22306121/ 연결]</ref> | ||
* [[SECURE]] | * [[SECURE]] | ||
{{참고}} | {{참고}} |